# KATHRYN MONOPOLI

**Phone:** +1-508-367-9077 | **Email:** krmonopoli@gmail.com  
**LinkedIn:** linkedin.com/in/kathrynmonopoli | **Website:** https://kmonopoli.github.io/

---

## PROFESSIONAL SUMMARY

Computational biologist with expertise in bioinformatics, genomics, and machine learning applications for drug discovery. Experienced developing high-throughput NGS analysis pipelines, performing transcriptomics analyses, and applying computational methods to therapeutic development. Strong combination of wet lab biology background and computational skills enables effective translation between experimental and computational teams. Proven track record of contributing to drug discovery programs with 34 molecules advancing to therapeutic pipelines.

---

## CORE COMPETENCIES

**Bioinformatics & Genomics:** NGS data analysis • RNA-seq & scRNA-seq • Transcriptomics • Sequence analysis • Genome annotation • Quality control pipelines • Differential expression analysis • Variant analysis • Multi-omics integration

**Computational Skills:** Python (10+ yrs) • R • Biopython • Bioconductor • DESeq2 • Scanpy • pysam • HTSeq • Statistical modeling • Data visualization • Pipeline development

**Machine Learning:** Predictive modeling • Feature engineering • Scikit-learn • TensorFlow • PyTorch • Model validation • Cross-validation • Supervised/unsupervised learning

**Technical Infrastructure:** Linux/Unix • Bash scripting • HPC/Slurm • AWS • Docker • Git • SQL • Database design • High-throughput automation

**Molecular Biology:** RNA biology • Oligonucleotide therapeutics • Protein biochemistry • Molecular cloning • Protein purification • Biophysical assays • Drug discovery

**Soft Skills:** Cross-functional collaboration • Project management • Scientific communication • Technical writing • Mentoring

---

## PROFESSIONAL EXPERIENCE

### Graduate Researcher, Bioinformatics & Computational Biology | UMass Chan Medical School, Worcester, MA
**2019 – 2025**

**Bioinformatics & NGS Analysis**
- **Developed and maintained high-throughput NGS analysis pipelines** processing RNA-seq and high-throughput screening data with automated quality control, read alignment, quantification, and downstream analysis
- **Performed comprehensive transcriptomic analyses** including differential expression, pathway enrichment, and gene ontology analysis to identify therapeutic targets and understand mechanism of action
- **Built automated QC and normalization workflows** ensuring data quality and reproducibility across multiple experimental batches and platforms
- **Conducted sequence analysis and motif identification** across thousands of RNA molecules to identify functional sequence determinants and optimize therapeutic designs

**Therapeutic Development & Drug Discovery**
- **Applied computational methods to direct design of 2,000+ therapeutic molecules** with 34 advancing to active drug discovery programs across neurological and infectious disease targets
- **Developed predictive models** integrating sequence, structural, and transcriptomic features to predict therapeutic efficacy, achieving 5-fold improvement in accuracy
- **Performed structure-activity relationship (SAR) analysis** identifying key molecular features driving therapeutic potency and selectivity
- **Contributed to 4 patent applications** for oligonucleotide therapeutics

**Data Management & Infrastructure**
- **Designed and implemented database systems** for organizing, storing, and retrieving experimental data including sequences, screening results, and metadata
- **Created reproducible computational workflows** using version control (Git), containerization (Docker), and HPC environments
- **Developed data visualization tools** generating publication-quality figures to communicate complex biological insights

**Collaboration & Communication**
- **Led software development project** coordinating engineering, computational, and experimental teams to deploy ML-powered therapeutic design platform
- **Collaborated extensively with wet lab scientists** to design experiments, interpret results, and validate computational predictions
- **Authored multiple publications** including manuscript in preparation for Nature Biotechnology and contributed analysis to grant applications

### Associate Scientist, Bioinformatics | Advirna (Biotech Startup), Cambridge, MA
**2016 – 2018**

- **Improved computational algorithms** for therapeutic RNA design, increasing throughput 5-fold
- **Developed predictive models** for oligonucleotide efficacy using sequence and structural features
- **Built cloud-based MySQL database platform** for therapeutic data management and retrieval across R&D teams
- **Performed sequence analysis and feature extraction** to identify design principles for functional oligonucleotides

### Researcher, Computational Biophysics | Institute for Protein Design (Baker Lab), Seattle, WA
**2016**

- **Implemented computational modeling components** in Rosetta protein folding software suite (C++)
- **Performed large-scale molecular modeling** utilizing high-throughput cloud computing infrastructure
- **Analyzed protein structure, dynamics, and stability** using computational biophysics approaches

### Graduate & Undergraduate Researcher, Biochemistry | University of Massachusetts Amherst
**2012 – 2015**

- **Designed and conducted biochemical and biophysical assays** to evaluate protein structure, dynamics, binding kinetics, and protein-protein interactions
- **Developed novel purification method** for membrane protein complexes formed in vivo
- **Performed molecular cloning, protein expression, and purification** for structural and functional studies

### Intern, Antibody Discovery | Biogen, Cambridge, MA
**2013**

- **Characterized therapeutic monoclonal antibodies** using BLI and ELISA for binding affinity, stability, and functionality
- **Developed Python-based computational parser** for antibody sequence analysis to accelerate epitope mapping

---

## EDUCATION

**PhD, Computational Biosciences & Bioengineering**  
UMass Chan Medical School & Worcester Polytechnic Institute | **November 2025**  
Advisors: Anastasia Khvorova (RNA Therapeutics), Dmitry Korkin (Bioinformatics & CS)  
*Thesis: Advanced machine learning methods for therapeutic siRNA design*

**MS, Molecular and Cellular Biology** | University of Massachusetts Amherst | **2015**  
Thesis-based, Phi Beta Kappa, GPA 4.0

**BS, Biochemistry & Molecular Biology** | University of Massachusetts Amherst | **2014**  
Honors College, *summa cum laude*, GPA 4.0

---

## TECHNICAL SKILLS

**Bioinformatics Tools:** Biopython, Bioconductor, DESeq2, Scanpy, HTSeq, pysam, STAR, Bowtie, SAMtools, BLAST, Clustal, MEME Suite

**Programming:** Python, R, Java, C++, SQL, Bash/Shell scripting

**Data Analysis:** Pandas, NumPy, SciPy, Statsmodels, Tidyverse, dplyr

**Machine Learning:** Scikit-learn, TensorFlow, PyTorch, XGBoost, statistical modeling

**Visualization:** Matplotlib, Seaborn, ggplot2, Plotly, IGV (Integrative Genomics Viewer)

**Infrastructure:** Linux/Unix, HPC/Slurm, AWS, Docker, Git/GitHub, CI/CD pipelines

**Databases:** MySQL, PostgreSQL, SQLite, database design

**Molecular Biology:** RNA biology, protein biochemistry, molecular cloning, protein purification, biophysical assays (BLI, ELISA, fluorescence), cell culture

---

## SELECTED PUBLICATIONS

- **Monopoli KR**, Sostek B, Gross K, Alterman J, Korkin D, Khvorova A. (2025) Applying advanced AI methods to define features of functional therapeutic siRNAs. *In preparation for Nature Biotechnology.*

- Davis SM, Hildebrand S, **Monopoli KR**, et al. (2025) Systematic Analysis of siRNA and mRNA Sequence Features Impacting Potency. *Nucleic Acids Research*.

- **Monopoli KR**, Korkin D, Khvorova A. (2023) Asymmetric trichotomous data partitioning enables predictive ML models using limited siRNA datasets. *Molecular Therapy: Nucleic Acids*.

- Shmushkovich T*, **Monopoli KR***, et al. (2018) Functional features defining efficacy of cholesterol-conjugated self-deliverable siRNAs. *Nucleic Acids Research*. *co-first authors

**Full publication list:** https://scholar.google.com/citations?user=fYt4EYcAAAAJ

---

## PATENTS

4 patent applications for oligonucleotide therapeutics targeting neurological diseases (MAPT, SNCA, MSH3) and infectious disease (SARS-CoV-2)

---

## SELECTED PRESENTATIONS

- **Invited Speaker**, American Society of Gene & Cell Therapy (ASGCT), Boston, MA (May 2026)
- **Oral Presentation**, Oligonucleotide Therapeutics Society (OTS), Budapest, Hungary (Oct 2025)
- **Oral Presentation**, Cold Spring Harbor Laboratory Nucleic Acid Therapies Meeting (Mar 2025)
- **Oral Presentation**, Intelligent Systems for Molecular Biology (ISMB), Madison, WI (Jul 2022)
- **Invited Speaker**, Oligonucleotide Therapeutics Society Webinar (Oct 2021)

---

## LEADERSHIP & MANAGEMENT

**Software Development Project Manager** | UMass Chan Medical School | 2023–2025
- Managed full product development lifecycle for bioinformatics platform integrating ML models
- Led technical recruitment, hiring, and onboarding; coordinated cross-functional teams
- Mentored junior computational scientists and engineers

**Teaching Assistant** | Worcester Polytechnic Institute & UMass Amherst | 2013–2014, 2018
- Computer Science: Introduction to Programming, Object-Oriented Design
- Biochemistry: Physical Chemistry, General Genetics

---

*References available upon request*